In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer
International Journal of Biological Sciences · 18.02.2026 · 22 (6) · 2950-2969
DOI: 10.7150/ijbs.124937 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 18.02.2026. Verfasst von Jian Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China. Hauptthemen laut MEDLINE: Ubiquitin-Conjugating Enzymes, Tuberous Sclerosis Complex 2 Protein, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
- Department of Traditional Chinese Medicine, The People's Hospital of Pingshan Shenzhen (Pingshan Hospital of Southern Medical University), Shenzhen, Guangdong, China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, Anhui, China.
- Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China.
- Shenzhen Clinical Medical School of Southern Medical University, China.
- Department of Oncology, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Zitieren
APA
Xu, J., Cheng, L., Ma, S., Gan, C., Chai, J., Zheng, X., Hu, L., Ling, M., Zhang, M., Zhao, B., & Cheng, H. (2026). In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer. International Journal of Biological Sciences, 22(6), 2950-2969. https://doi.org/10.7150/ijbs.124937
Vancouver
Xu J, Cheng L, Ma S, Gan C, Chai J, Zheng X, et al. In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer. International Journal of Biological Sciences. 2026;22(6):2950-2969. doi:10.7150/ijbs.124937
BibTeX
@article{Xu2026,
author = {Xu, Jian and Cheng, Ling and Ma, Sien and Gan, Chen and Chai, Jiaying and Zheng, Xinyi and Hu, Longyu and Ling, Meiwen and Zhang, Mingjun and Zhao, Bao and Cheng, Huaidong},
title = {In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer},
journal = {International Journal of Biological Sciences},
year = {2026},
volume = {22},
number = {6},
pages = {2950--2969},
doi = {10.7150/ijbs.124937}
}
EUVIMED